Sanofi inks $1.7B Inhibrx buyout, snagging rare disease drug but spinning out cancer programs
Sanofi inks $1.7B Inhibrx buyout, snagging rare disease drug but spinning out cancer programs
ntaylor
Tue, 01/23/2024 - 05:27
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *